Evidence map›Paper›PMID 34104490›Full record

ArticleArab journal of urology2020

Robot-assisted radical prostatectomy in the Middle East: A report on the perioperative outcomes from a tertiary care centre in Lebanon.

Muhieddine Labban, Muhammad Bulbul, Wassim Wazzan, Raja Khauli, Albert El Hajj

Abstract read
In one paragraph

Article in Arab journal of urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Muhieddine LabbanDivision of Urology, Department of Surgery, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.ORCID https://orcid.org/0000-0002-4580-1915
Muhammad BulbulDivision of Urology, Department of Surgery, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.
Wassim WazzanDivision of Urology, Department of Surgery, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.
Raja KhauliDivision of Urology, Department of Surgery, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.
Albert El HajjDivision of Urology, Department of Surgery, American University of Beirut Medical Center (AUBMC), Beirut, Lebanon.ORCID https://orcid.org/0000-0002-0043-7195

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo report on the surgical, oncological and early functional outcomes of robot-assisted radical prostatectomy (RARP) at our tertiary care centre, as there is a scarcity of reports on outcomes of robotic surgery from the Middle East. PATIENTS AND

methodsWe reviewed the electronic health records for patients undergoing RARP between 2013 and 2019 at the American University of Beirut Medical Center. We collected patients' demographics and preoperative oncological factors including prostate-specific antigen (PSA), clinical oncological stage, and World Health Organization (WHO) grade. PSA persistence, biochemical recurrence (BCR) and positive surgical margin (PSM) were reported. Complications were categorised by Clavien-Dindo grade. Moreover, the postoperative oncological outcomes including the rates of adjuvant and salvage androgen-deprivation therapy (ADT) and external-beam radiation therapy (EBRT), chemotherapy, and metastasis were reported. Additionally continence and potency results were retrieved.

resultsFor the designated period, 250 patients underwent RARP of which 182 (72.8%) underwent lymph node dissection. The median (interquartile range) anaesthesia time was 330 (285-371) min and the estimated blood loss was 200 (200-300) mL. The overall complication rate was 8%, with 2% Clavien-Dindo Grade III-IV complications. The PSM and BCR rates were 21.6% and 6.4%, respectively. Adjuvant ADT and EBRT was administered to 7.2% of the patients. Functional data was available for 112 patients. Continence was 68%, 82% and 97% of the patients at 3, 6 and 12 months, respectively. For 65 patients who had bilateral nerve sparing potency was 37%, 60% and 83% at 3, 6 and 12 months, respectively.

conclusionThis is the largest RARP series from the Middle East. The surgical, oncological and functional outcomes are consistent with those published in the literature. This confirms the safety and efficacy of applying robotic technology in our region during the implementation phase.

Indexed as

Middle Eastperioperative outcomesprostate cancerrobot-assisted radical prostatectomyrobotics

Identifiers

PMID34104490
PMCPMC8158259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.